On August 27th, 2025, UCLA Law Center on Reproductive Health, Law, and Policy (CRHLP) and Advancing New Standards in Reproductive Health (ANSIRH) at UCSF submitted a letter on behalf of more than 260 researchers to the U.S. Food and Drug Administration (FDA). The letter affirms the 25-year safety record of mifepristone, explains why recent reports that attempt to muddy that record lack scientific rigor and reliability, and urges the FDA to continue grounding any future decisions in transparent, rigorous science. 

CRHLP helped organize this letter alongside ANSIRH as part of our ongoing work to ensure that law and policy are informed by rigorous science and research. 

The full letter can be found here.